WQ
HQL

Wealth Quarterback’s abrdn Life Sciences Investors HQL Stock Holding History

Wealth Quarterback’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2K Hold
50
– – ﹤0.01% 720
2021
Q2 		$2K Buy
+50
New +$1.01K ﹤0.01% 750

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Wealth Quarterback's HQL Position: Q3 2021 in Review

Wealth Quarterback held its abrdn Life Sciences Investors (HQL) position steady in Q3 2021 at 50 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Wealth Quarterback first reported a position in HQL in Q2 2021 and has held it in 2 quarters since. 67 funds tracked by Wall St. Rank hold HQL as of Q3 2021.

  • Wealth Quarterback held 50 shares of abrdn Life Sciences Investors worth $2K as of Q3 2021.
  • Wealth Quarterback left its abrdn Life Sciences Investors share count unchanged in Q3 2021.
  • abrdn Life Sciences Investors made up ﹤0.01% of Wealth Quarterback's portfolio in Q3 2021, its #720 holding.
  • Wealth Quarterback first reported a position in abrdn Life Sciences Investors in Q2 2021 and has held it in 2 quarters since.
  • 67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.